-
ECONOMIC OPTIMIZATION OF POLYMYXIN B EXPOSURE TARGETS USING AN INTEGRATED PHARMACOMETRIC-PHARMACOECONOMIC SIMULATION FRAMEWORK
Aug 11, 2026, 17:16 PM -
SOCIOECONOMIC DISPARITIES ACROSS THE NON-SMALL CELL LUNG CANCER PRECISION ONCOLOGY PATHWAY: A SCOPING REVIEW AND EVIDENCE GAP MAP
Aug 11, 2026, 17:16 PM -
ECONOMIC IMPACT OF CDST USE IN CROHN'S DISEASE: A FRENCH BUDGET IMPACT MODEL
Aug 11, 2026, 17:16 PM -
COMPARING GRACE TO CURRENT METHODOLOGIES IN HEALTH AND TRANSPORT ECONOMICS - APPLICATION TO NONFATAL ROAD TRAFFIC INJURIES BASED ON RISK PREFERENCES AMONG THE SWEDISH GENERAL POPULATION
Aug 11, 2026, 17:16 PM -
REAL-WORLD CHARACTERIZATION OF IPF AND PPF PATIENTS IN SPAIN: CLINICAL FEATURES, DIAGNOSIS AND HRQOL (RECOFIB STUDY)
Aug 11, 2026, 17:16 PM -
DOES AREA DEPRIVATION EXPLAIN GEOGRAPHIC VARIATION IN ACCESS TO ADVANCED THERAPIES FOR STAGE IV NON-SMALL CELL LUNG CANCER IN ENGLAND?
Aug 11, 2026, 17:16 PM -
C-PEPTIDE AS A HEALTH ECONOMIC ENDPOINT IN TYPE 1 DIABETES (T1D): SYSTEMATIC REVIEW EVIDENCE FOR COST-EFFECTIVENESS MODELING OF DISEASE-MODIFYING THERAPIES (DMTS)
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVALUATION OF TIME TO NEXT TREATMENT (TTNT) AND TIME TO TREATMENT DISCONTINUATION (TTD) AS SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN IMMUNE CHECKPOINT INHIBITOR-TREATED LUNG CANCER
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF PSORIASIS WITH CONCURRENT OR SUBSEQUENT PSORIATIC ARTHRITIS: A RETROSPECTIVE OBSERVATIONAL STUDY IN GERMANY
Aug 11, 2026, 17:16 PM -
BRINGING TACROLIMUS MONITORING HOME: A DISCRETE CHOICE EXPERIMENT OF PATIENT PREFERENCES IN ORGAN TRANSPLANTATION
Aug 11, 2026, 17:16 PM -
REAL-WORLD COMPARATOR EVIDENCE FOR BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: DERIVATION OF AN NHS ENGLAND REGISTRY COHORT TO SUPPORT INDIRECT COMPARATIVE EFFECTIVENESS ANALYSES
Aug 11, 2026, 17:16 PM -
TRANSLATION QUALITY AS AN UNDERRECOGNIZED DETERMINANT OF DATA VALIDITY IN MULTINATIONAL HEOR: A CONCEPTUAL FRAMEWORK
Aug 11, 2026, 17:16 PM -
AN ANALYSIS OF IV-TO-SUBCUTANEOUS ONCOLOGY DRUG TRANSITIONS FRAMED BY IMPLEMENTATION SCIENCE: WHY CLINICAL EFFICACY ALONE FAILS TO DRIVE ADOPTION
Aug 11, 2026, 17:16 PM -
ESTIMATING THE FISCAL IMPACT OF MENOPAUSE SYMPTOMS IN ENGLAND AND WALES: A PUBLIC FINANCE FRAMEWORK FOR THE EVALUATION OF MENOPAUSE INTERVENTIONS
Aug 11, 2026, 17:16 PM -
NICE EVALUATIONS OF AI AND DIGITAL TECHNOLOGIES
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF TRANSCUTANEOUS CARBON DIOXIDE THERAPY VERSUS STANDARD OF CARE FOR DIABETIC FOOT ULCER HEALING AND AMPUTATION PREVENTION: A MODEL-BASED ANALYSIS FROM THE SWISS PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
A COST-UTILITY ANALYSIS OF SUBCUTANEOUS VERSUS ORAL METHOTREXATE FOR TREATMENT OF RHEUMATOID ARTHRITIS IN PORTUGAL
Aug 11, 2026, 17:16 PM -
CLINICAL IDENTIFICATION AND MANAGEMENT PATTERNS IN ALCOHOL USE DISORDER (AUD): EVIDENCE FROM NORSTELLALINQ STRUCTURED AND HUMAN-IN-THE-LOOP LARGE LANGUAGE MODEL (LLM) EXTRACTED CLINICAL DATA
Aug 11, 2026, 17:16 PM -
INTEGRATING MULTILEVEL NETWORK META-REGRESSION (ML-NMR) INTO EXCEL COST-EFFECTIVENESS MODELS USING CONDITIONAL M-SPLINE SURVIVAL CURVES
Aug 11, 2026, 17:16 PM -
MORTALITY FROM EXTERNAL CAUSES IN COLOMBIA'S FIVE LARGEST CITIES: 2000-2024
Aug 11, 2026, 17:16 PM
